Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:14631868rdf:typepubmed:Citationlld:pubmed
pubmed-article:14631868lifeskim:mentionsumls-concept:C0005038lld:lifeskim
pubmed-article:14631868lifeskim:mentionsumls-concept:C0080103lld:lifeskim
pubmed-article:14631868lifeskim:mentionsumls-concept:C1882726lld:lifeskim
pubmed-article:14631868lifeskim:mentionsumls-concept:C0010798lld:lifeskim
pubmed-article:14631868lifeskim:mentionsumls-concept:C0038836lld:lifeskim
pubmed-article:14631868lifeskim:mentionsumls-concept:C0441655lld:lifeskim
pubmed-article:14631868lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:14631868lifeskim:mentionsumls-concept:C1979928lld:lifeskim
pubmed-article:14631868lifeskim:mentionsumls-concept:C0079411lld:lifeskim
pubmed-article:14631868lifeskim:mentionsumls-concept:C1550605lld:lifeskim
pubmed-article:14631868lifeskim:mentionsumls-concept:C0456205lld:lifeskim
pubmed-article:14631868lifeskim:mentionsumls-concept:C0604267lld:lifeskim
pubmed-article:14631868pubmed:issue3-4lld:pubmed
pubmed-article:14631868pubmed:dateCreated2003-11-24lld:pubmed
pubmed-article:14631868pubmed:abstractTextLiver microsomal cytochrome P4502E1-dependent p-nitrophenol (PNP) hydroxylation and expression of cytochrome P4502E1 were studied in rats subjected to gamma-hexachlorocyclohexane (HCCH) or L-3,3,5-triiodothyronine (T3) administration as a possible mechanism contributing to superoxide radical (O2.-) generation. HCCH treatment (a single dose of 40 mg/kg body wt) produced a 43% increase in the content of total cytochrome P450, whereas T3 (daily doses of 0.1 mg/kg body wt for two consecutive days) led to a 37% decrease. NADPH-dependent O2.- generation was elevated by HCCH and T3, expressed as either per mg of protein or per nmol of cytochrome P450, with a 135% enhancement in the O2.- production/superoxide dismutase (SOD) activity ratios being observed in both conditions. This was partly due to depression of SOD activity. Concomitantly, the molecular activity of NADPH-cytochrome p450 reductase was enhanced by 90 and 69% by HCCH and T3, respectively. In these conditions, microsomal PNP hydroxylation showed increases of 58 and 45% in HCCH- and T3-treated rats over control values, respectively, with a parallel 31% (HCCH) and 41% (T3) enhancement in the content of cytochrome P4502E1 assessed by western immunoblotting. We conclude that HCCH and T3 enhance the expression and activity of cytochrome P4502E1 and that of NADPH-cytochrome P450 reductase in rat liver, regardless of the changes in total cytochrome P450 content, representing major contributory mechanisms to microsomal NADPH-dependent O2.- generation.lld:pubmed
pubmed-article:14631868pubmed:languageenglld:pubmed
pubmed-article:14631868pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14631868pubmed:citationSubsetIMlld:pubmed
pubmed-article:14631868pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14631868pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14631868pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14631868pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14631868pubmed:statusMEDLINElld:pubmed
pubmed-article:14631868pubmed:issn0716-9760lld:pubmed
pubmed-article:14631868pubmed:authorpubmed-author:D'AlmeidaVâni...lld:pubmed
pubmed-article:14631868pubmed:authorpubmed-author:FernándezVirg...lld:pubmed
pubmed-article:14631868pubmed:authorpubmed-author:GiavarottiLea...lld:pubmed
pubmed-article:14631868pubmed:authorpubmed-author:AzzalisLigia...lld:pubmed
pubmed-article:14631868pubmed:authorpubmed-author:VidelaLuis...lld:pubmed
pubmed-article:14631868pubmed:authorpubmed-author:Simon-Giavaro...lld:pubmed
pubmed-article:14631868pubmed:authorpubmed-author:QuiñonesLuisLlld:pubmed
pubmed-article:14631868pubmed:authorpubmed-author:MassaLauraLlld:pubmed
pubmed-article:14631868pubmed:authorpubmed-author:JunqueiraVirg...lld:pubmed
pubmed-article:14631868pubmed:issnTypePrintlld:pubmed
pubmed-article:14631868pubmed:volume36lld:pubmed
pubmed-article:14631868pubmed:ownerNLMlld:pubmed
pubmed-article:14631868pubmed:authorsCompleteYlld:pubmed
pubmed-article:14631868pubmed:pagination359-65lld:pubmed
pubmed-article:14631868pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:14631868pubmed:meshHeadingpubmed-meshheading:14631868...lld:pubmed
pubmed-article:14631868pubmed:meshHeadingpubmed-meshheading:14631868...lld:pubmed
pubmed-article:14631868pubmed:meshHeadingpubmed-meshheading:14631868...lld:pubmed
pubmed-article:14631868pubmed:meshHeadingpubmed-meshheading:14631868...lld:pubmed
pubmed-article:14631868pubmed:meshHeadingpubmed-meshheading:14631868...lld:pubmed
pubmed-article:14631868pubmed:meshHeadingpubmed-meshheading:14631868...lld:pubmed
pubmed-article:14631868pubmed:meshHeadingpubmed-meshheading:14631868...lld:pubmed
pubmed-article:14631868pubmed:meshHeadingpubmed-meshheading:14631868...lld:pubmed
pubmed-article:14631868pubmed:meshHeadingpubmed-meshheading:14631868...lld:pubmed
pubmed-article:14631868pubmed:meshHeadingpubmed-meshheading:14631868...lld:pubmed
pubmed-article:14631868pubmed:year2003lld:pubmed
pubmed-article:14631868pubmed:articleTitleEffects of gamma-hexachlorocyclohexane and L-3,3',5-triiodothyronine on rat liver cytochrome P4502E1-dependent activity and content in relation to microsomal superoxide radical generation.lld:pubmed
pubmed-article:14631868pubmed:affiliationPrograma de Farmacología Molecular y Clínica, Instituto de Ciencias Biomédicas, Facultad de Medicina, Universidad de Chile, Casilla 70000, Santiago-7, Chile. vfernand@machi.med.uchile.cllld:pubmed
pubmed-article:14631868pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:14631868pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed